Results 1 - 20 of 1,391 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (1,263)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatmentCA: a cancer journal for clinicians, 2018-03, Vol.68 (2), p.153-165 [Peer Reviewed Journal]2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Mar/Apr 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21443 ;PMID: 29338071Full text available |
| 2 |
Material Type: Article
|
|
Limits to Personalized Cancer MedicineThe New England journal of medicine, 2016-09, Vol.375 (13), p.1289-1294 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb1607705 ;PMID: 27682039Full text available |
| 3 |
Material Type: Article
|
|
The high price of anticancer drugs: origins, implications, barriers, solutionsNature reviews. Clinical oncology, 2017-06, Vol.14 (6), p.381-390 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2017 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2017.31 ;PMID: 28290490 ;CODEN: AJHYE6Full text available |
| 4 |
Material Type: Article
|
|
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML expertsBlood, 2013-05, Vol.121 (22), p.4439-4442 [Peer Reviewed Journal]2013 American Society of Hematology ;2013 by The American Society of Hematology 2013 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2013-03-490003 ;PMID: 23620577Full text available |
| 5 |
Material Type: Article
|
|
Economic burden of cancer across the European Union: a population-based cost analysisThe lancet oncology, 2013-11, Vol.14 (12), p.1165-1174 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2013 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70442-X ;PMID: 24131614 ;CODEN: LANCAOFull text available |
| 6 |
Material Type: Article
|
|
Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs FundAnnals of oncology, 2017-08, Vol.28 (8), p.1738-1750 [Peer Reviewed Journal]2017 THE AUTHORS ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx110 ;PMID: 28453615Full text available |
| 7 |
Material Type: Article
|
|
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional surveyThe lancet oncology, 2021-10, Vol.22 (10), p.1367-1377 [Peer Reviewed Journal]2021 World Health Organization ;2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;2021 World Health Organization 2021 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00463-0 ;PMID: 34560006Full text available |
| 8 |
Material Type: Article
|
|
Drug repurposing in oncology--patient and health systems opportunitiesNature reviews. Clinical oncology, 2015-12, Vol.12 (12), p.732-742 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2015 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2015.169 ;PMID: 26483297 ;CODEN: AJHYE6Full text available |
| 9 |
Material Type: Article
|
|
Cancer Drugs in the United States: Justum Pretium—The Just PriceJournal of clinical oncology, 2013-10, Vol.31 (28), p.3600-3604 [Peer Reviewed Journal]2014 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.49.1845 ;PMID: 23650428Full text available |
| 10 |
Material Type: Article
|
|
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for OncologyJournal of clinical oncology, 2012-05, Vol.30 (14), p.1715-1724 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2012.42.8375 ;PMID: 22493340Full text available |
| 11 |
Material Type: Article
|
|
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid LeukemiaJournal of clinical oncology, 2014-02, Vol.32 (4), p.306-311 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2013.52.9123 ;PMID: 24366936Full text available |
| 12 |
Material Type: Article
|
|
Economic burden of cancer in the United States: estimates, projections, and future researchCancer epidemiology, biomarkers & prevention, 2011-10, Vol.20 (10), p.2006-2014 [Peer Reviewed Journal]2011 AACR ;ISSN: 1055-9965 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.epi-11-0650 ;PMID: 21980008Full text available |
| 13 |
Material Type: Article
|
|
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling studyThe Lancet infectious diseases, 2015-12, Vol.15 (12), p.1429-1437 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2015 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(15)00270-4 ;PMID: 26482597 ;CODEN: LANCAOFull text available |
| 14 |
Material Type: Article
|
|
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare BeneficiariesJournal of clinical oncology, 2017-08, Vol.35 (22), p.2482-2489 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.72.3742 ;PMID: 28471711Full text available |
| 15 |
Material Type: Article
|
|
How Much Longer Will We Put Up With $100,000 Cancer Drugs?Cell, 2017-02, Vol.168 (4), p.579-583 [Peer Reviewed Journal]2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2017.01.034 ;PMID: 28187281Full text available |
| 16 |
Material Type: Article
|
|
Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015Annals of oncology, 2017-05, Vol.28 (5), p.1111-1116 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx053 ;PMID: 28453694Full text available |
| 17 |
Material Type: Article
|
|
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011Journal of clinical oncology, 2015-07, Vol.33 (19), p.2190-2196 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.58.2320 ;PMID: 25987701Full text available |
| 18 |
Material Type: Article
|
|
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison studyThe lancet oncology, 2016-01, Vol.17 (1), p.39-47 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00449-0 ;PMID: 26670089Full text available |
| 19 |
Material Type: Article
|
|
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesJournal of clinical oncology, 2018-02, Vol.36 (4), p.319-325 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.72.2124 ;PMID: 29016226Full text available |
| 20 |
Material Type: Article
|
|
Pricing in the Market for Anticancer DrugsThe Journal of economic perspectives, 2015, Vol.29 (1), p.139-162 [Peer Reviewed Journal]Copyright © 2015 American Economic Association ;Copyright American Economic Association Winter 2015 ;ISSN: 0895-3309 ;EISSN: 1944-7965 ;DOI: 10.1257/jep.29.1.139 ;PMID: 28441702Full text available |
Results 1 - 20 of 1,391 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (1,263)
Refine My Results
Creation Date
- Before 1997 (19)
- 1997 To 2002 (117)
- 2003 To 2008 (243)
- 2009 To 2015 (634)
- After 2015 (379)
-
More options
New Records
Resource Type
- Articles (1,358)
- magazinearticle (30)
- Books (2)
- Conference Proceedings (1)
-
More options
Subject
- Antineoplastic Agents - Economics (1,388)
- Humans (1,355)
- Science & Technology (1,119)
- Life Sciences & Biomedicine (1,095)
- Antineoplastic Agents - Therapeutic Use (842)
- Oncology (572)
- Cost-Benefit Analysis (488)
- Neoplasms - Drug Therapy (388)
- Female (382)
- Drug Costs (369)
- Neoplasms - Economics (311)
- Cancer (309)
- United States (307)
- Health Care Sciences & Services (268)
- Chemotherapy (263)
- Male (241)
- Cancer Therapies (219)
- Middle Aged (218)
- General & Internal Medicine (197)
- Medicine, General & Internal (197)
-
More options
Databases
- MEDLINE (1,388)
- ProQuest Central (802)
- GFMER Free Medical Journals (542)
- HighWire Press (Free Journals) (297)
- PubMed Central (248)
- DOAJ Directory of Open Access Journals (239)
- ProQuest One Psychology (133)
- ROAD: Directory of Open Access Scholarly Resources (127)
- SpringerOpen (65)
- Wiley-Blackwell Titles (Open access) (43)
- Open Access: Freely Accessible Journals by multiple vendors (38)
- Open Access: Nature Open Access (28)
- RePEc (22)
- PLoS (Open access) (19)
- Journals@Ovid Open Access Journal Collection Rolling (18)
- Oxford Open (Open Access) (18)
- Cambridge Wholly Gold Open Access Journals (15)
- BMJ Open Access Journals (15)
- Taylor & Francis (Open access) (11)
- IngentaConnect Free/Open Access Journals (10)
-
More options
Language
Journal Title
- Annals Of Oncology (32)
- Bmj (90)
- Bmj : British Medical Journal (23)
- Health Technology Assessment (39)
- Jnci : Journal Of The National Cancer Institute (65)
- Journal Of Clinical Oncology (62)
- Journal Of Oncology Practice (44)
- Pharmacoeconomics (67)
- The American Journal Of Managed Care (37)
- The Lancet Oncology (48)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||